Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Century Communities, Inc. $400 Million Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with the Rule 144A and Regulation S…
Century Communities, Inc. $400 Million Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in connection with the Rule 144A and Regulation S…
DexCom, Inc. $350 Million Convertible Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by DexCom, Inc. of $350 million…
Hexion Inc. $75 Million Reopening of First-Priority Senior Secured Notes due 2022
Davis Polk advised the initial purchaser on a Rule 144A/Regulation S offering by Hexion Inc. in connection with an add-on…
Kaman $175 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Kaman…
Intel Corporation $6.5 Billion Notes Offering
Davis Polk advised the joint bookrunning managers in connection with a $6.5 billion SEC-registered debt offering by Intel…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300…
Intel Corporation $6.5 Billion Notes Offering
Davis Polk advised the joint bookrunning managers in connection with a $6.5 billion SEC-registered debt offering by Intel…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300…